- Home
- NMFC vs INMD Comparison
NMFC vs INMD Comparison
Compare NMFC & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMFC
- INMD
- Stock Information
- Founded
- NMFC 2010
- INMD 2008
- Country
- NMFC United States
- INMD Israel
- Employees
- NMFC N/A
- INMD N/A
- Industry
- NMFC Finance/Investors Services
- INMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- NMFC Finance
- INMD Health Care
- Exchange
- NMFC Nasdaq
- INMD Nasdaq
- Market Cap
- NMFC 1.2B
- INMD 1.5B
- IPO Year
- NMFC 2011
- INMD 2019
- Fundamental
- Price
- NMFC $11.27
- INMD $17.20
- Analyst Decision
- NMFC Hold
- INMD Buy
- Analyst Count
- NMFC 2
- INMD 6
- Target Price
- NMFC $11.50
- INMD $22.60
- AVG Volume (30 Days)
- NMFC 567.5K
- INMD 883.8K
- Earning Date
- NMFC 10-30-2024
- INMD 02-11-2025
- Dividend Yield
- NMFC 11.36%
- INMD N/A
- EPS Growth
- NMFC N/A
- INMD N/A
- EPS
- NMFC 1.04
- INMD 1.84
- Revenue
- NMFC $373,513,000.00
- INMD $423,746,000.00
- Revenue This Year
- NMFC $1.68
- INMD N/A
- Revenue Next Year
- NMFC N/A
- INMD $3.13
- P/E Ratio
- NMFC $10.85
- INMD $9.30
- Revenue Growth
- NMFC 4.95
- INMD N/A
- 52 Week Low
- NMFC $10.62
- INMD $14.87
- 52 Week High
- NMFC $13.10
- INMD $26.80
- Technical
- Relative Strength Index (RSI)
- NMFC 38.53
- INMD 40.62
- Support Level
- NMFC $11.08
- INMD $16.96
- Resistance Level
- NMFC $11.45
- INMD $18.64
- Average True Range (ATR)
- NMFC 0.17
- INMD 0.63
- MACD
- NMFC -0.08
- INMD -0.21
- Stochastic Oscillator
- NMFC 21.84
- INMD 19.47
About NMFC New Mountain Finance Corporation
New Mountain Finance Corp is a closed-end, non-diversified management investment company. It invests in equity interests such as preferred stock, common stock, warrants, or options received in connection with debt investments or may include direct investment in the equity of private companies. The company's investment objective is to generate current income and capital appreciation through sourcing and origination of debt securities at all levels of the capital structure, including first and second-lien debt, notes, bonds, and mezzanine securities.
About INMD InMode Ltd.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.